Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• LEUPRORELIN ACETATE (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Hormone Suppressors (drug)
• Paclitaxel (drug) — also listed as: Abraxane
• Radiation Therapy (radiation)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• cabergoline (drug)
• Aspirin (drug)
• GnRH agonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Kasr Alainy medical school
  Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• LeuplinⓡInj (drug)
• CKD-841 (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Severance Hospital
  Seoul, Yonsei-ro, Seodaemun-gu 50-1, South Korea
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• TAK-700 and LHRH agonist (drug) — also listed as: Orteronel (TAK 700), LHRH-Leuprorelin Acetate
• prostatectomy (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• St Bartholomew's Hospital
  London, United Kingdom
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GnRH antagonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• National Institutes of Health Clinical Center, 9000 Rockville Pike
  Bethesda, Maryland, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• depot leuprolide acetate 3.75 mg (drug) — also listed as: LUPRON depot 3.75 mg
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Michigan
  Ann Arbor, Michigan, United States
  Site recruitment: Not reported
• The Ohio State University
  Columbus, Ohio, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• abiraterone acetate (drug) — also listed as: Zytiga
• prednisone (drug) — also listed as: DeCortin, Deltra
• leuprolide acetate (drug) — also listed as: Enantone, Lupron, Lupron Depot
• laboratory biomarker analysis (other)
• external beam radiation therapy (radiation)
• goserelin acetate (drug) — also listed as: Zoladex

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  Seattle, Washington, United States
  Site recruitment: Not reported
• MultiCare Regional Cancer Center - Tacoma
  Tacoma, Washington, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• docetaxel (drug) — also listed as: Taxotere
• leuprolide acetate (drug) — also listed as: Lupron, Eligard, Viadur, Zoladex
• radiation therapy (radiation)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
  Chapel Hill, North Carolina, United States
  Site recruitment: Not reported
• Rex Cancer Center at Rex Hospital
  Raleigh, North Carolina, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• sipuleucel-T (biological) — also listed as: PROVENGE®, APC8015
• leuprolide acetate (drug) — also listed as: Eligard®

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Urology Center of Alabama
  Homewood, Alabama, United States
  Site recruitment: Not reported
• University of California San Diego / Moores Cancer Center
  La Jolla, California, United States
  Site recruitment: Not reported
• Keck Hospital of USC
  Los Angeles, California, United States
  Site recruitment: Not reported
• LAC + USC Medical Center
  Los Angeles, California, United States
  Site recruitment: Not reported
• USC / Norris Comprehensive Cancer Center
  Los Angeles, California, United States
  Site recruitment: Not reported
• The Urology Center of Colorado
  Denver, Colorado, United States
  Site recruitment: Not reported
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  Baltimore, Maryland, United States
  Site recruitment: Not reported
• Comprehensive Cancer Centers of Nevada
  Las Vegas, Nevada, United States
  Site recruitment: Not reported
• NYOH Albany Cancer Center at Patroon Creek
  Albany, New York, United States
  Site recruitment: Not reported
• Community Care Physicians, PC
  Albany, New York, United States
  Site recruitment: Not reported
• Grand Strand Urology
  Myrtle Beach, South Carolina, United States
  Site recruitment: Not reported
• Urology San Antonio Research
  San Antonio, Texas, United States
  Site recruitment: Not reported
• Virginia Mason Medical Center
  Seattle, Washington, United States
  Site recruitment: Not reported
• Seattle Cancer Care Alliance
  Seattle, Washington, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Everolimus, lupron, bicalutamide, and radiation (other) — also listed as: afinitor, RAD-001, Casodex, Leuprolide, Eligard

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Georgetown University
  Washington D.C., District of Columbia, United States
  Site recruitment: Not reported
• University of Michigan Comprehensive Cancer Center
  Ann Arbor, Michigan, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Docetaxel (drug) — also listed as: Taxotere, Docecad
• Bevacizumab (drug) — also listed as: Avastin
• ADT (drug) — also listed as: Lupron or Zoladex
• Bicalutamide (drug) — also listed as: Casodex, Cosudex, Calutide, Kalumid

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Maryland - Greenebaum Cancer Center
  Baltimore, Maryland, United States
  Site recruitment: Not reported
• Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States
  Site recruitment: Not reported
• Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dendritic Cells DCVAC/PCa (biological)
• Leuprolide acetate (drug) — also listed as: Lupron
• Goserelin Acetate (drug) — also listed as: Zoladex

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Facility not reported
  Jablonec nad Nisou, Czechia
  Site recruitment: Not reported
• Facility not reported
  Jihlava, Czechia
  Site recruitment: Not reported
• Facility not reported
  Liberec, Czechia
  Site recruitment: Not reported
• Facility not reported
  Mníšek pod Brdy, Czechia
  Site recruitment: Not reported
• Facility not reported
  Olomouc, Czechia
  Site recruitment: Not reported
• Facility not reported
  Pilsen, Czechia
  Site recruitment: Not reported
• Facility not reported
  Prague, Czechia
  Site recruitment: Not reported
• Facility not reported
  Ústí nad Labem, Czechia
  Site recruitment: Not reported
• Facility not reported
  Zlín, Czechia
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Bicalutamide (drug) — also listed as: Casodex, Cosudex, ICI 176,334, ICI 176334
• Flutamide (drug) — also listed as: 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Chimax, Drogenil, Euflex, Eulexin, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolid, Oncosal, Profamid, Prostacur, Prostadirex, Prostica, Prostogenat, SCH 13521, Tafenil, Tecnoflut, Testotard
• Goserelin Acetate (drug) — also listed as: ZDX, Zoladex
• Ipilimumab (drug) — also listed as: Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS-734016, MDX-010, MDX-CTLA4, Yervoy
• Leuprolide Acetate (drug) — also listed as: A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur
• Pharmacological Study (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Mayo Clinic
  Rochester, Minnesota, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• leuprolide acetate FluidCrystal® injection depot (drug) — also listed as: CAM2032
• leuprolide acetate (drug) — also listed as: Eligard

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Docrates Cancer Center
  Helsinki, Finland
  Site recruitment: Not reported
• University Hospital of Helsinki, Department of Urology
  Helsinki, Finland
  Site recruitment: Not reported
• Tampere University Hospital, Department of Urology
  Tampere, Finland
  Site recruitment: Not reported
• University Hospital of Turku, Department of Urology
  Turku, Finland
  Site recruitment: Not reported
• Semmelweis University Hospital Department of Urology
  Budapest, Hungary
  Site recruitment: Not reported
• Szent Imre Teaching Hospital
  Budapest, Hungary
  Site recruitment: Not reported
• University of Debrecen, Medical Health Sciences Center, Department of Urology
  Debrecen, Hungary
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprolide acetate (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Cancer Centre of Southeastern Ontario
  Kingston, Ontario, Canada
  Site recruitment: Not reported
• Ottawa Hospital Regional Cancer Centre
  Ottawa, Ontario, Canada
  Site recruitment: Not reported
• Kingston General Hospital
  Ottawa, Ontario, Canada
  Site recruitment: Not reported
• Ottawa Hospital/OHRI
  Ottawa, Ontario, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprorelin acetate (drug) — also listed as: Leuplin SR 11.25 mg Injection Kit

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Ethinyl Estradiol-Levonorgestrel combination (drug) — also listed as: Portia 21, Portia 28
• leuprolide acetate (drug) — also listed as: Eligard
• Estradiol (drug) — also listed as: Vivelle-Dot
• Progesterone (drug) — also listed as: First-Progesterone VGS

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Oregon Health & Sciences University, Department of Obstetrics and Gynecology, Women's Health Research Unit
  Portland, Oregon, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Eligard (drug) — also listed as: Leuprorelin acetate

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Site NL31005 St. Antonius ziekenhuis
  Nieuwegein, Netherlands
  Site recruitment: Not reported
• Site NL31004 Radboudumc
  Nijmegen, Netherlands
  Site recruitment: Not reported
• Site NL31001 Canisius-Wilhelmina Ziekenhuis
  Nijmegen, Netherlands
  Site recruitment: Not reported